| Literature DB >> 32023449 |
Stuti Agarwal1, Zachary Kraus1, Jessica Dement-Brown1, Oyeleye Alabi1, Kyle Starost1, Mate Tolnay2.
Abstract
Human Fc receptor-like 3 (FCRL3) is an orphan receptor expressed by lymphocytes, including regulatory T cells. FCRL3 is implicated in several autoimmune diseases; however, its function on regulatory T cells is unknown. We discovered that FCRL3 stimulation of regulatory T cells inhibited their suppressive function. Moreover, FCRL3 stimulation induced IL-17, IL-26, and IFNγ production and promoted expression of the Th17-defining transcription factor RORγt without affecting FOXP3 expression. We suggest that FCRL3 engagement mediates a transition of regulatory T cells to a pro-inflammatory Th17-like phenotype. In addition, we identified secretory IgA as a specific FCRL3 ligand. Secretory IgA could serve as an environmental cue for mucosal breaches and locally drive regulatory T cell plasticity to help control infection. Our findings define a mechanism that explains the recognized association of FCRL3 with autoimmune diseases. Targeting FCRL3 to modulate regulatory T cell activity could be exploited to treat both malignancies and autoimmune diseases. Published by Elsevier Inc.Entities:
Keywords: autoimmunity; immunotherapy; inflammation; mucosal immunity; regulatory T cell; secretory IgA
Year: 2020 PMID: 32023449 DOI: 10.1016/j.celrep.2019.12.099
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423